Jeil Pharma Holdings Inc
KRX:002620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jeil Pharma Holdings Inc
KRX:002620
|
KR |
|
A
|
Aramis Group SAS
F:6T6
|
FR |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
|
Marico Ltd
BSE:531642
|
IN |
|
Bosideng International Holdings Ltd
HKEX:3998
|
HK |
|
Piccadily Agro Industries Ltd
BSE:530305
|
IN |
|
A
|
Alma Media Oyj
LSE:0DJN
|
FI |
|
N
|
NuVasive Inc
F:NK8
|
US |
|
H
|
HD Renewable Energy Co Ltd
TWSE:6873
|
TW |
|
A
|
Aryt Industries Ltd
TASE:ARYT
|
IL |
|
Advanced Share Registry Ltd
ASX:ASW
|
AU |
|
Goertek Inc
SZSE:002241
|
CN |
|
R
|
Readboy Education Holding Co Ltd
HKEX:2385
|
CN |
Bankruptcy Probability
Jeil Pharma Holdings Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Jeil Pharma Holdings Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Jeil Pharma Holdings Inc
KRX:002620
|
132.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
854.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Jeil Pharma Holdings Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Jeil Pharma Holdings Inc has total debt of 164.1B KRW. This includes both short-term (146.9B KRW) and long-term (17.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
